Construction of a therapeutic effect evaluation system for patients with primary liver cancer based on syndrome differentiation in traditional Chinese medicine

Journal of Chinese Integrative Medicine

Volumn 5, Issue 1, 2007, Pages 15-22

  Li, Dong Tao ^a,b   Ling, Chang Quan ^a   Lang, Qing Bo ^a   Zhu, De Zeng ^a   Yu, Chao Qin ^a   Chen, Zhe ^a   Zhai, Xiao Feng ^a   Shen, Jie ^a   Zhang, Jin Feng ^a   Zhang, Bai Hong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Department of Traditional Chinese Medicine   (China)

Author keywords

Analytic hierarchy process; Curative effect evaluation; Liver cancer; Syndrome; Traditional Chinese medicine

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; CHINESE MEDICINE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EVALUATION RESEARCH; FEMALE; HUMAN; INTERMETHOD COMPARISON; KARNOFSKY PERFORMANCE STATUS; LIVER CANCER; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; RELIABILITY; SCORING SYSTEM; SYNDROME DELINEATION; THERAPY EFFECT;

EID: 33846537295     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20070104     Document Type: Article

References (43)

1. Chinese Association of Psychiatry. Chinese Classification of Mental Disorders - Third Edition (CCMD-3). Jinan: Shandong Scientific and Technical Publishers. 2001: 4. Chinese.
2. Ye YW, Wang YS. Operating instruction for clinical laboratory tests in China. 2nd ed. Nanjing: Southeast University Press. 1997: 410-414. Chinese.
3. Deng TT. Traditional Chinese medicine diagnostics. 5th ed. Shanghai: Shanghai Scientific and Technical Publishers. 1984: 11. Chinese.
4. Luo YJ. Evaluation of clinical application of the simplified McGill Pain Questionnaire. Zhongguo Kang Fu. 1992; 7(4): 160-164. Chinese.
5. Chen WB. Diagnostics. 5th ed. Beijing: People's Medical Publishing House. 2002: 6. Chinese.
6. Ye RG. Internal medicine. 5th ed. Beijing: People's Medical Publishing House. 2002: 6. Chinese.
7. Kuang HL. Differential diagnostics of internal medicine. 3rd ed. Beijing. People's Medical Publishing House. 1997: 12. Chinese.
8. Zhao JD. Differential diagnostics of symptoms in traditional Chinese medicine. Beijing: People's Medical Publishing House. 1987. 6. Chinese.
9. Li ZM. Differential diagnostics of clinical symptoms. 3rd ed. Shanghai: Shanghai Scientific and Technical Publishers. 1995: 3. Chinese.
10. Zheng XY. Guiding principles for clinical research on new drugs of traditional Chinese medicine. Beijing: Chinese Medical Science and Technology Press. 2002: 5. Chinese.
11. Jing YQ. Modern research and clinical practice of theories about the liver in traditional Chinese medicine. Beijing: People's Medical Publishing House. 2000: 1. Chinese.
12. Committee of Liver Cancer of the Chinese Anti-Cancer Association. Criteria for diagnosis and staging of primary liver cancer. Zhong Liu Fang Zhi Yan Jiu. 2002; 29(1): 83. Chinese.
13. Dai RW, Cao LB. Research of hall of workshop of metasynthetic engineering. Guan Li Ke Xue Xue Bao. 2002; 5(3): 10-16. Chinese with abstract in English.
14. Cui X, Dai RW, Li YD. The emergence of collective wisdom in the hall for workshop of metasynthetic engineering. Xi Tong Fang Zhen Xue Bao. 2003; 15(1): 146-153. Chinese with abstract in English.
15. Wang DL, Dai RW. Behavior criterion for expert group in hall for workshop of metasynthetic engineering. Guan Li Ke Xue Xue Bao. 2001; 4(2): 1-6. Chinese with abstract in English.
16. Nickel JC. Effective office management of chronic prostatitis. Urol Clin North Am. 1998; 25(4): 677-684.
17. Guan JD, Wan X, Hu LS. Study on the methodology of the quantification of TCM symptoms and assessment of therapeutic effects. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002; 22(6): 431. Chinese.
18. You S, Hu LS. Study on the methodology of the quantification of TCM symptoms and syndromes. Beijing Zhong Yi Yao Da Xue Xue Bao, 2002; 25(2): 13-15. Chinese with abstract in English.
19. Yu SL. Medical Statistics. Beijing: People's Medical Publishing House. 2002: 386-390. Chinese.
20. Heffernan N, Cella D, Webster K, et al. Measuring health-related quality of life in patients with hepatobiliary cancer: the functional assessment of cancer therapy-hepatobiliary questionnaire. J Clin Oncol. 2002; 20(9): 2229-2239.
21. Zhou T, Liu SQ, Liu JW. The evaluation of curative effect in the therapy of medical oncology. Yi Xue Yu Zhe Xue. 2001; 22(9): 6-7. Chinese with abstract in English.
22. Bao YH, Li JJ. Introduction to the revised Response Evaluation Criteria in Solid Tumors (RECIST). Zhongguo Fei Ai Za Zhi. 2005; 8(1): 77-78. Chinese.
23. Men BY, Li F, Gao HY. Methods of the evaluation of prognosis and long term therapeutic efficacy on malignant tumor (Part 1): survival analysis. Xian Dai Zhong Liu Yi Xue. 2003; 11(3): 81-86. Chinese.
24. Luo FT. Survival analysis of follow-up data. In: Ni ZZ. Medical statistics. 4th ed. Beijing: People's Medical Publishing House. 2000: 209-222. Chinese.
25. Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res. 1995; 4(6): 523-531.
26. WHO. The development of the WHO quality of life assessment instrument. Geneve: WHO. 1993.
27. Karnofsky DA. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer. 1948; 1: 634-656.
28. Cull A, Aaronson N, Ahmedzai S, et al. The European organization for research and treatment of cancer (EORTC) modular approach to quality of life assessment in oncology: an update. Qual Life Newsletter. 1996; (13-14): 1-2, 8.
29. Bonomi AE, Cella DF. A cross-cultural adaptation of the functional assessment of cancer therapy (FACT) quality of life measurement system for use in European oncology clinical trials. Qual Life Newsletter. 1995: (12): 5-71.
30. Men BY, Li F, Gao HY. Methods of the evaluation of prognosis and long term therapeutic efficacy on malignant tumor (Part 2): quality of life measurement. Xian Dai Zhong Liu Yi Xue. 2003; 11(3): 161-163. Chinese.
31. Zhao JB, Li YH, Chen Y, et al. Evaluation of the quality of life in the patients with primary hepatocellular carcinoma after interventional therapy: A multiple center investigation. Lin Chuang Fang She Xue Za Zhi. 2002; 21(7): 550-552. Chinese with abstract in English.
32. Lin LM, Zhang SQ. Evaluation of hepatic artery chemoembolization combined with percutaneous ethanol injection in the treatment of hepatocellular carcinoma. Yi Xue Ying Xiang Xue Za Zhi. 2005; 15(1). 34-36. Chinese with abstract in English.
33. Wang LJ, Dong YQ, Li XD, et al. Effect observation on treatment of hepatoma with Aidi injection combined with FAP chemotherapy plan. Zhonghua Ming Yi Lun Tan. 2005; (2): 33-34. Chinese.
34. Meng ZQ, Xu YY, Liu LM, et al. Clinical evaluation of integration of transcatheter arterial chemoembolization and traditional Chinese medicine in treating metastatic liver cancer. Zhong Xi Yi Jie He Xue Bao. 2003; 1(3): 187-188, 233. Chinese with abstract in English.
35. Ling CQ. Problems in cancer treatment and major research of integrative medicine. Zhong Xi Yi Jie He Xue Bao. 2003; 1(3): 168-170. Chinese with abstract in English.
36. Chen KJ. Evaluation of clinical therapeutic effect for traditional Chinese medicine. Zhong Xi Yi Jie He Xue Bao. 2005; 3(1): 1-2. Chinese with abstract in English.
37. Ling CQ, Liu Q, Li DT. et al. Study of a qualitative diagnostic criterion for basic syndromes of traditional Chinese medicine in patients with primary liver cancer. Zhong Xi Yi Be He Xue Bao. 2005; 3(2): 95-98. Chinese with abstract in English.
38. Wang J, Wang YY. Complex system theory and recipe pattern research in traditional Chinese medicine. Zhongguo Zhong Yi Yao Xin Xi Za Zhi. 2001; 8(9): 25-27. Chinese.
39. Zhu ZH. Medical science and system complexity theory. Xi Tong Fang Zhen Xue Bao. 2002; 14(11): 1425-1428, 1438. Chinese with abstract in English.
40. Waldrop MM. Complexity: the emerging science at the edge of order and chaos. New York: Simon & Schuster. 1992.
41. Dong XH, Dai RW. Traditional Chinese medicine in views of system science and system complexity. Xi Tong Fang Zhen Xue Bao. 2002; 14(11): 1458-1463, 1478. Chinese with abstract in English.
42. Qian XS. A new discipline of science: the study of open complex giant system and its methodology. Zi Ran Za Zhi. 1990: 13(1): 3-10. Chinese with abstract in English.
43. Qian XS. Recognition on open complex giant system. Mo Shi Shi Bie Yu Ren Gong Zhi Neng. 1991; 4(1): 1-4. Chinese with abstract in English.